Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 262

1.

Ablation of perivascular hepatic malignant tumors with irreversible electroporation.

Kingham TP, Karkar AM, D'Angelica MI, Allen PJ, Dematteo RP, Getrajdman GI, Sofocleous CT, Solomon SB, Jarnagin WR, Fong Y.

J Am Coll Surg. 2012 Sep;215(3):379-87. doi: 10.1016/j.jamcollsurg.2012.04.029. Epub 2012 Jun 16.

PMID:
22704820
2.

Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma.

Martin RC 2nd, McFarland K, Ellis S, Velanovich V.

J Am Coll Surg. 2012 Sep;215(3):361-9. doi: 10.1016/j.jamcollsurg.2012.05.021. Epub 2012 Jun 21.

PMID:
22726894
3.

Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up.

Dollinger M, Müller-Wille R, Zeman F, Haimerl M, Niessen C, Beyer LP, Lang SA, Teufel A, Stroszczynski C, Wiggermann P.

PLoS One. 2015 Aug 13;10(8):e0135773. doi: 10.1371/journal.pone.0135773. eCollection 2015. Erratum in: PLoS One. 2015;10(8):e0137480.

4.

Irreversible electroporation for the ablation of liver tumors: are we there yet?

Charpentier KP.

Arch Surg. 2012 Nov;147(11):1053-61. doi: 10.1001/2013.jamasurg.100. Review.

PMID:
23165618
5.

Midterm Safety and Efficacy of Irreversible Electroporation of Malignant Liver Tumors Located Close to Major Portal or Hepatic Veins.

Distelmaier M, Barabasch A, Heil P, Kraemer NA, Isfort P, Keil S, Kuhl CK, Bruners P.

Radiology. 2017 Dec;285(3):1023-1031. doi: 10.1148/radiol.2017161561. Epub 2017 Aug 11.

PMID:
28799842
6.

Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures.

Cannon R, Ellis S, Hayes D, Narayanan G, Martin RC 2nd.

J Surg Oncol. 2013 Apr;107(5):544-9. doi: 10.1002/jso.23280. Epub 2012 Oct 22.

PMID:
23090720
7.

Factors associated with short-term local recurrence of liver cancer after percutaneous ablation using irreversible electroporation: a prospective single-center study.

Niessen C, Igl J, Pregler B, Beyer L, Noeva E, Dollinger M, Schreyer AG, Jung EM, Stroszczynski C, Wiggermann P.

J Vasc Interv Radiol. 2015 May;26(5):694-702. doi: 10.1016/j.jvir.2015.02.001. Epub 2015 Mar 23.

PMID:
25812712
8.

Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies.

Pearson AS, Izzo F, Fleming RY, Ellis LM, Delrio P, Roh MS, Granchi J, Curley SA.

Am J Surg. 1999 Dec;178(6):592-9.

PMID:
10670879
9.

Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience and review of safety and outcomes.

Cheung W, Kavnoudias H, Roberts S, Szkandera B, Kemp W, Thomson KR.

Technol Cancer Res Treat. 2013 Jun;12(3):233-41. doi: 10.7785/tcrt.2012.500317. Epub 2013 Jan 25.

PMID:
23369152
10.

Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results.

Frühling P, Nilsson A, Duraj F, Haglund U, Norén A.

Eur J Surg Oncol. 2017 Apr;43(4):751-757. doi: 10.1016/j.ejso.2016.12.004. Epub 2017 Jan 11.

PMID:
28109674
11.

Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience.

Martin RC, Scoggins CR, McMasters KM.

Ann Surg Oncol. 2010 Jan;17(1):171-8. doi: 10.1245/s10434-009-0686-z. Epub 2009 Aug 26.

PMID:
19707829
12.

Irreversible Electroporation for Colorectal Liver Metastases.

Scheffer HJ, Melenhorst MC, Echenique AM, Nielsen K, van Tilborg AA, van den Bos W, Vroomen LG, van den Tol PM, Meijerink MR.

Tech Vasc Interv Radiol. 2015 Sep;18(3):159-69. doi: 10.1053/j.tvir.2015.06.007. Epub 2015 Jun 18. Review.

PMID:
26365546
13.

Irreversible electroporation ablation of malignant hepatic tumors: subacute and follow-up CT appearance of ablation zones.

Dollinger M, Jung EM, Beyer L, Niessen C, Scheer F, Müller-Wille R, Stroszczynski C, Wiggermann P.

J Vasc Interv Radiol. 2014 Oct;25(10):1589-94. doi: 10.1016/j.jvir.2014.06.026. Epub 2014 Aug 23.

PMID:
25156648
14.

Long-term survival after radiofrequency ablation of complex unresectable liver tumors.

Amersi FF, McElrath-Garza A, Ahmad A, Zogakis T, Allegra DP, Krasne R, Bilchik AJ.

Arch Surg. 2006 Jun;141(6):581-7; discussion 587-8.

PMID:
16785359
15.

Percutaneous Ablation of Hepatic Tumors Using Irreversible Electroporation: A Prospective Safety and Midterm Efficacy Study in 34 Patients.

Niessen C, Beyer LP, Pregler B, Dollinger M, Trabold B, Schlitt HJ, Jung EM, Stroszczynski C, Wiggermann P.

J Vasc Interv Radiol. 2016 Apr;27(4):480-6. doi: 10.1016/j.jvir.2015.12.025. Epub 2016 Feb 26.

PMID:
26922979
16.

Radiofrequency ablation of unresectable liver tumors: factors associated with incomplete ablation or local recurrence.

Ayav A, Germain A, Marchal F, Tierris I, Laurent V, Bazin C, Yuan Y, Robert L, Brunaud L, Bresler L.

Am J Surg. 2010 Oct;200(4):435-9. doi: 10.1016/j.amjsurg.2009.11.009. Epub 2010 Apr 20.

PMID:
20409524
17.

Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm.

Bilchik AJ, Wood TF, Allegra D, Tsioulias GJ, Chung M, Rose DM, Ramming KP, Morton DL.

Arch Surg. 2000 Jun;135(6):657-62; discussion 662-4.

PMID:
10843361
18.

Bile Duct Injury after Irreversible Electroporation of Hepatic Malignancies: Evaluation of MR Imaging Findings and Laboratory Values.

Dollinger M, Zeman F, Niessen C, Lang SA, Beyer LP, Müller M, Stroszczynski C, Wiggermann P.

J Vasc Interv Radiol. 2016 Jan;27(1):96-103.

PMID:
26777402
19.

Percutaneous ablation of peribiliary tumors with irreversible electroporation.

Silk MT, Wimmer T, Lee KS, Srimathveeravalli G, Brown KT, Kingham PT, Fong Y, Durack JC, Sofocleous CT, Solomon SB.

J Vasc Interv Radiol. 2014 Jan;25(1):112-8. doi: 10.1016/j.jvir.2013.10.012. Epub 2013 Nov 18.

PMID:
24262034
20.

Adverse effects of irreversible electroporation of malignant liver tumors under CT fluoroscopic guidance: a single-center experience.

Dollinger M, Beyer LP, Haimerl M, Niessen C, Jung EM, Zeman F, Stroszczynski C, Wiggermann P.

Diagn Interv Radiol. 2015 Nov-Dec;21(6):471-5. doi: 10.5152/dir.2015.14442.

Supplemental Content

Support Center